Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2018

Open Access 01-06-2018 | Clinical trial

Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study

Authors: James R. Harvey, Yit Lim, John Murphy, Miles Howe, Julie Morris, Amit Goyal, Anthony J. Maxwell

Published in: Breast Cancer Research and Treatment | Issue 3/2018

Login to get access

Abstract

Purpose

Wire localization has several disadvantages, notably wire migration and difficulty scheduling the procedure close to surgery. Radioactive seed localization overcomes these disadvantages, but implementation is limited due to radiation safety requirements. Magnetic seeds potentially offer the logistical benefits and transcutaneous detection equivalence of a radioactive seed, with easier implementation. This study was designed to evaluate the feasibility and safety of using magnetic seeds for breast lesion localization.

Methods

A two-centre open-label cohort study to assess the feasibility and safety of magnetic seed (Magseed) localization of breast lesions. Magseeds were placed under radiological guidance into women having total mastectomy surgery. The primary outcome measure was seed migration distance. Secondary outcome measures included accuracy of placement, ease of transcutaneous detection, seed integrity and safety.

Results

Twenty-nine Magseeds were placed into the breasts of 28 patients under ultrasound guidance. There was no migration of the seeds between placement and surgery. Twenty-seven seeds were placed directly in the target lesion with the other seeds being 2 and 3 mm away. All seeds were detectable transcutaneously in all breast sizes and at all depths. There were no complications or safety issues.

Conclusions

Magnetic seeds are a feasible and safe method of breast lesion localization. They can be accurately placed, demonstrate no migration in this feasibility study and are detectable in all sizes and depths of breast tissue. Now that safety and feasibility have been demonstrated, further clinical studies are required to evaluate the seed’s effectiveness in wide local excision surgery.
Literature
1.
go back to reference Rahusen FD, Bremers AJA, Fabry HFJ et al (2002) Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol 9:994–998CrossRefPubMed Rahusen FD, Bremers AJA, Fabry HFJ et al (2002) Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol 9:994–998CrossRefPubMed
3.
go back to reference Langhans L, Tvedskov TF, Klausen TL et al (2017) Radioactive seed localization or wire-guided localization of nonpalpable invasive and in situ breast cancer: a randomized, multicenter, Open-label Trial. Ann Surg 266(1):29–35CrossRefPubMed Langhans L, Tvedskov TF, Klausen TL et al (2017) Radioactive seed localization or wire-guided localization of nonpalpable invasive and in situ breast cancer: a randomized, multicenter, Open-label Trial. Ann Surg 266(1):29–35CrossRefPubMed
5.
go back to reference Rampaul RS, Bagnall M, Burrell H et al (2004) Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. Br J Surg 91:1575–1577CrossRefPubMed Rampaul RS, Bagnall M, Burrell H et al (2004) Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. Br J Surg 91:1575–1577CrossRefPubMed
6.
go back to reference Thill M, Kurylcio A, Welter R et al (2014) The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope. Breast 23(2):175–179CrossRefPubMed Thill M, Kurylcio A, Welter R et al (2014) The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope. Breast 23(2):175–179CrossRefPubMed
7.
go back to reference Mango VL, Wynn RT, Feldman S et al (2017) Beyond wires and seeds: reflector-guided breast lesion localization and excision. Radiology 284(2):365–371CrossRefPubMed Mango VL, Wynn RT, Feldman S et al (2017) Beyond wires and seeds: reflector-guided breast lesion localization and excision. Radiology 284(2):365–371CrossRefPubMed
8.
go back to reference Schermersac B, van der Hagea JA, Loob CE et al (2017) Feasibility of magnetic marker localization for non-palpable breast cancer. Breast 33:50–56CrossRef Schermersac B, van der Hagea JA, Loob CE et al (2017) Feasibility of magnetic marker localization for non-palpable breast cancer. Breast 33:50–56CrossRef
9.
go back to reference Zhang Y, Seely J, Cordeiro E et al (2017) Radioactive seed localization versus wire-guided localization for nonpalpable breast cancer: a cost and operating room efficiency analysis. Ann Surg Oncol 12:3567–3573CrossRef Zhang Y, Seely J, Cordeiro E et al (2017) Radioactive seed localization versus wire-guided localization for nonpalpable breast cancer: a cost and operating room efficiency analysis. Ann Surg Oncol 12:3567–3573CrossRef
Metadata
Title
Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study
Authors
James R. Harvey
Yit Lim
John Murphy
Miles Howe
Julie Morris
Amit Goyal
Anthony J. Maxwell
Publication date
01-06-2018
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-4709-y

Other articles of this Issue 3/2018

Breast Cancer Research and Treatment 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine